Hautarzt最新文献_第9页

COVID-19-Impfung : Erythema exsudativum multiforme als unerwünschte Impfreaktion. 脑组织训练

4区医学

Hautarzt Pub Date : 2022-01-01 DOI: 10.1007/s00105-021-04921-2

K Wunderlich

引用次数: 0

[From dog sniffing via dermoscopy to dysplastic nevus]. [从狗通过皮肤镜嗅探到发育不良的痣]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-07-21 DOI: 10.1007/s00105-021-04865-7

Andreas Blum, Matthias Viehmann, Bruno E Paredes

引用次数: 0

[Erythema multiforme following COVID-19 vaccination (BNT162b2)]. [COVID-19疫苗接种后多形性红斑(BNT162b2)]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-10-21 DOI: 10.1007/s00105-021-04911-4

K Wunderlich, T Dirschka

引用次数: 9

[Areas of application for teledermatology]. [远程皮肤科的应用领域]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-11-05 DOI: 10.1007/s00105-021-04917-y

P Reinders, M Otten, M Augustin, B Stephan, N Kirsten

{"title":"[Areas of application for teledermatology].","authors":"P Reinders, M Otten, M Augustin, B Stephan, N Kirsten","doi":"10.1007/s00105-021-04917-y","DOIUrl":"https://doi.org/10.1007/s00105-021-04917-y","url":null,"abstract":"Background: In recent years, the introduction of the E‑Health Act and the relaxation of the ban on remote treatment has improved the framework for telemedicine in Germany.Objectives: The aim of this article is to present an overview of the evidence of different areas of application for teledermatology.Materials and methods: A narrative review of national and international studies and projects on the use of teledermatology for diagnosis, monitoring of diseases, triage between primary care physicians (PCPs) and dermatologists, and its use in facilities with reduced organizational and/or geographical access to specialist care was conducted.Results: Diagnostic applications allow teledermatological assessment in a large proportion of cases, with high concordance of diagnosis and patient satisfaction. For the monitoring of patients, the majority of studies demonstrated no difference in effectiveness between on-site and remote consultation, while patients are spared travel distance and waiting time. For programs enabling triage most of the patients with dermatologic conditions were able to remain with the PCP, while acute patients requiring direct referral to a dermatologist were identified. In special facilities, such as prisons, dermatological teleconsultations are successfully utilized.Conclusion: An adequate framework and promising evidence for the use of teledermatology exist. The areas of application are described in detail within the German S2k guideline for teledermatology. However, there is a potential risk for decreased access to telemedicine services for certain population groups.","PeriodicalId":12970,"journal":{"name":"Hautarzt","volume":"73 1","pages":"47-52"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569498/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39593593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 7

[Access to health care throughout the country]. [在全国范围内获得医疗保健]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-11-30 DOI: 10.1007/s00105-021-04916-z

A Kis, J Augustin

{"title":"[Access to health care throughout the country].","authors":"A Kis, J Augustin","doi":"10.1007/s00105-021-04916-z","DOIUrl":"https://doi.org/10.1007/s00105-021-04916-z","url":null,"abstract":"The legal basis for describing the regional care situation is based on the adjusted supply rate of the 'demand planning guideline'. However, it provides only limited information about the accessibility of medical care which is crucial for the reality of patients' lives. The aim of this review is to present geographic approaches that spatially measure access to dermatological care in its physical and digital dimension. Here, on the one hand, the classical geographic parameter 'accessibility' is addressed, and on the other hand, data from the Federal Ministry of Transport and Digital Infrastructure (BMVI) on broadband coverage are presented as access parameters of teledermatological applications. In addition to the methodological approach, limitations and potentials in the interpretation of the results, minimum standards are also considered. The access parameters presented here make it possible to investigate spatial disparities and to present them clearly via cartographic representations. While the example of accessibility with a car shows almost area-wide access to the nearest dermatology practice (≤ 30 min), investigations on public transport accessibility reveal rather heterogeneous accessibility. Particularly in the identification of 'dual care gaps', sub-areas with poor physical and digital accessibility, these approaches could support and advance the application of alternative care models. However, the approaches presented here focus on potential accessibility. Further dimensions on actual physician utilisation or availability-also with regard to minimum standards-should be the subject of future research.","PeriodicalId":12970,"journal":{"name":"Hautarzt","volume":"73 1","pages":"40-46"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39790650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

[Early onset of methotrexate-associated lymphoproliferative disorder mimicking Hodgkin's lymphoma]. [早期发病的甲氨蝶呤相关淋巴细胞增生性疾病，模拟霍奇金淋巴瘤]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-04-01 DOI: 10.1007/s00105-021-04804-6

Maria Rosa Burg, Stefan W Schneider

引用次数: 1

[Regional variations in healthcare for patients with psoriasis and atopic dermatitis in Germany]. [德国银屑病和特应性皮炎患者医疗保健的地区差异]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-11-25 DOI: 10.1007/s00105-021-04913-2

M Augustin, C Garbe, S Neitemeier, T Steimle, S Schwarz, J Augustin, R von Kiedrowski, K Hagenström

{"title":"[Regional variations in healthcare for patients with psoriasis and atopic dermatitis in Germany].","authors":"M Augustin, C Garbe, S Neitemeier, T Steimle, S Schwarz, J Augustin, R von Kiedrowski, K Hagenström","doi":"10.1007/s00105-021-04913-2","DOIUrl":"https://doi.org/10.1007/s00105-021-04913-2","url":null,"abstract":"Background: Psoriasis (Pso) and atopic dermatitis (AD) are chronic skin diseases that result in significant physical and psychological impairment, financial burden, and loss of quality of life. According to previous data, there are regional differences in healthcare.Objectives: The aim was to analyse the epidemiology as well as the treatment of insured people with Pso and AD in Germany in a regional comparison.Methods: Data of the insurance company Techniker Krankenkasse for the year 2019 regarding treatment prevalences as well as drug prescriptions on the regional level for all physicians were examined.Results: In 2019 the overall prevalence of Pso was 2.5% (about 2 million insured people in Germany) and AD was 4.2% (about 3.6 million insured people). In Pso, new guideline-compliant drugs were frequently utilised, yet systemic glucocorticosteroids (GCS) were still disproportionally prescribed. Regionally, there were pronounced disparities with higher prescription rates of the new drugs in the north and east. Insured people with AD most frequently received topical GCS (approx. 88%), of which most were class III (66%), and significantly less frequently calcineurin inhibitors (< 10%), which also conform to guidelines. Systemically, GCS were by far most commonly used (about 25% of all insured people with drug prescriptions). Dupilumab, the only long-term drug approved in 2019, was very rarely prescribed, accounting for less than 1%. Again, large regional differences similar to Pso were found.Conclusion: Pso and AD show relevant disparities and gaps in drug care in the regional comparison despite uniform national guidelines and patient needs. The barriers to appropriate modern pharmaceuticals need to be clarified and mitigated.","PeriodicalId":12970,"journal":{"name":"Hautarzt","volume":"73 1","pages":"27-39"},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39925190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

[Relevance of health geographic research for dermatology]. [健康地理研究与皮肤病的相关性]。

4区医学

Hautarzt Pub Date : 2022-01-01 Epub Date: 2021-11-30 DOI: 10.1007/s00105-021-04912-3

J Augustin, M Sander, D Koller

引用次数: 0

Atopische Dermatitis : Aktuelles zur Spezifischen Immuntherapie. 皮炎:特定免疫治疗功能更新

4区医学

Hautarzt Pub Date : 2021-12-01 DOI: 10.1007/s00105-021-04910-5

Stephan Traidl, Thomas Werfel

引用次数: 0

[Quality of care for patients with atopic dermatitis in Germany-no improvements in indicators after ten years]. 【德国特应性皮炎患者的护理质量——十年后各项指标没有改善】。

4区医学

Hautarzt Pub Date : 2021-12-01 Epub Date: 2021-09-20 DOI: 10.1007/s00105-021-04885-3

A Langenbruch, N Mohr, F Abeck, J Schmitt, S Ständer, T Werfel, D Thaçi, S Weidinger, M Augustin

{"title":"[Quality of care for patients with atopic dermatitis in Germany-no improvements in indicators after ten years].","authors":"A Langenbruch, N Mohr, F Abeck, J Schmitt, S Ständer, T Werfel, D Thaçi, S Weidinger, M Augustin","doi":"10.1007/s00105-021-04885-3","DOIUrl":"https://doi.org/10.1007/s00105-021-04885-3","url":null,"abstract":"Background: With AtopicHealth1, the first national care study on atopic dermatitis (AD) was conducted in 2010. At that time, about one third of the patients undergoing treatment by dermatologists showed severe limitations in quality of life, which indicated an insufficient quality of care. The aim of the present study was to characterise the current care of patients with AD undergoing dermatological treatment in comparison between different severity grades, as well as in comparison to 2010 and to psoriasis.Methods: The Germany-wide multicentre cross-sectional study \"AtopicHealth2\" recorded clinical data, quality of life (DLQI), therapies, preventive behaviour and patient-defined treatment benefit (PBI). Patients with an indication for systemic therapy were considered moderately to severely affected for subgroup analyses, the others mildly affected.Results: Between 2017 and 2019, 1291 patients (median age 41 years, 56.5% female) were enrolled by 111 centres. Compared with 2010, there were no improvements in quality of life (DLQI 8.5 in both studies), severity (SCORAD 45.4 vs. 42.3 in 2010) or treatment benefit (PBI 2.2 vs. 2.4 in 2010). Moderately to severely affected patients were more likely to show impaired quality of life (45.4% vs. 23.6%) and less likely to have relevant treatment benefits (PBI < 1: 21.3% vs. 13.2%) than mildly affected patients. In contrast to psoriasis, patients with AD revealed higher quality of life limitations (DLQI 8.5 vs. 6.1) and lower treatment benefit (PBI 2.2 vs. 2.8).Discussion: Compared to 2010, there is no improvement in the quality of care for AD in Germany. Compared to psoriasis, patients with AD show higher burden and lower treatment benefit, which underlines the need for therapeutic innovations.","PeriodicalId":12970,"journal":{"name":"Hautarzt","volume":"72 12","pages":"1079-1089"},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39432965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1